Gain Therapeutics, Inc. (GANX)

NasdaqGM - NasdaqGM Real-time price. Currency in USD

Add to watchlist

1.1795

+0.0595

(+5.36%)

As of 02:57PM EDT. Market open.

Insider roster

Individual or entity	Most-recent transaction	Date	Shares owned as of transaction date
ALDER MATTHIAS Chief Executive Officer	Conversion of Exercise of derivative security	25 Mar 2024	21,140
CALABRESE SALVATORE Chief Financial Officer	Purchase	18 May 2022	3,000
RICHMAN ERIC I. Director	Purchase	30 Jun 2024	304,458
RILEY JEFFREY SCOTT Director	Purchase	27 Mar 2024	30,000
*Insider roster data is derived solely from the last 24 months of Form 3 & Form 4 SEC filings.